Germany’s BaFin looking into possible insider trading of CureVac shares 2021-06-21T10:59:18-04:00June 21st, 2021| share this article! German financial watchdog BaFin is investigating possible insider trading of vaccine maker’s CureVac shares, which fell after the biotech firm announced its COVID-19 vaccine proved only 47% effective, Rheinische Post newspaper reported on Monday. Read More share this article! Related Posts Why the Retail Industry Could Outperform This Year May 2nd, 2024 Pennsylvania Man Sentenced To Prison For Role In Multi-Million Dollar Pandemic Fraud Scheme May 2nd, 2024 Bitcoin Mining Profitability Hits An All Time Low, But Here’s Who Is Still Thriving May 2nd, 2024 The Updated FAQs on the Corporate Transparency Act (CTA) May 2nd, 2024
